Selegiline induces dopamine release through ATP-sensitive potassium channels in the rat caudate-putamen in vitro

Neurochemistry International

Volumn 31, Issue 2, 1997, Pages 307-311

  Neusch, Clemens ^a   Schnierle, Senta ^a   Moser, Andreas ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BUTANEDIONE; ADENOSINE TRIPHOSPHATE; CROMAKALIM; DOPAMINE; MONOAMINE OXIDASE INHIBITOR; NOMIFENSINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; QUINPIROLE; SELEGILINE; SULPIRIDE; TOLBUTAMIDE;

ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; CULTURE MEDIUM; DOPAMINE RELEASE; ENANTIOMER; ENZYME INHIBITION; FEMALE; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; TISSUE CULTURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CAUDATE NUCLEUS; DOPAMINE; FEMALE; MONOAMINE OXIDASE INHIBITORS; NEUROPROTECTIVE AGENTS; POTASSIUM CHANNELS; PUTAMEN; RATS; RATS, WISTAR; SELEGILINE;

ANIMALIA;

EID: 0030919580     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00132-5     Document Type: Article

References (19)

1. 2+ in mouse pancreatic ß-cells following stimulation by hypoglycemic sulfonylureas. FEBS Lett. 190, 21-24.
2. + channels. Science 247, 852-854.
3. +-channels. Cell Signal 2, 197-214.
4. Ben-Ary, Y. (1990) Galanin and glibenclamide modulate the anoxic release of glutamate in rat CA3 hippocampal neurons. Eur. J. Neurosci. 2, 62-68.
5. Bensadoun, A. and Weinstein, D. (1976) Assay of protein in the presence of interfering materials. Analyt. Biochem. 70, 241-250.
6. +-channels in pancreatic B-cells. Nature 311, 271-273.
7. Fang, J. and Yu, P. H. (1994) Effect of 1-deprenyl, its analogues and some monoamine oxidase inhibitors on dopamine uptake. Neuropharmacology 33, 763-768.
8. Hausser, M. A., De Weille, J. R. and Lazdunski, M. (1991) Activation by cromakalim of pre- and postsynaptic ATP-sensitive potassium channels in the substantia nigra. Biochem. Biophys. Res. Commun. 174, 909-914.
9. Knoll, J., Toth, V., Kummert, M. and Sugar, J. (1992) (-)Deprenyl and (-)para-fluoro-deprenyl treatment prevents age-related pigment changes in substantia nigra. A TV-image analysis of neuromelanin. Mech. Age. Developm. 63, 157-163.
10. 2 receptors to increase potassium conductance in neurons of the rat substantia nigra zona compacta. J. Physiol. 392, 397-416.
11. Moser, A., Scholz, J., Bamberg, H. and Böhme, V. (1996) The effect of N-methyl-norsalsolinol on monoamine oxidase of the rat caudate nucleus in vitro. Neurochem. Int. 28, 109-112.
12. Mourre, C., Ben-Ary, Y., Bernardi, H., Fosset, M. and Lazdunski, M. (1989) Antidiabetic sulfonylureas: localization of binding sites in the brain and effects on the hyperpolarization induced by anoxia in hippocampal slices. Brain Res. 486, 159-164.
13. +-channels in cardiac muscle. Nature 305, 147-148.
14. Reynolds, G. P., Elsworth, J. D., Blau, K., Sandler, M., Lees, A. J. and Stern, G. M. (1978) Deprenyl is metabolized to methamphetamine and amphetamine in man. Br. J. Clin. Pharmac. 6, 542-544.
15. B receptors on isolated substantia nigra neurons. Pflüg. Archs. 416, 473-475.
16. Spruce, A. E., Standen, N. B. and Stanfield, P. R. (1985) Voltage-dependent ATP-sensitive potassium channels of skeletal muscle membrane. Nature 316, 736-738.
17. Tanaka, T., Yoshida, M., Yokoo, H., Mizoguchi, K. and Tanaka, M. (1995) The role of ATP-sensitive potassium channels in striatal dopamine release: an in vivo microdialysis study. Pharmacol. Biochem. Behav. 52, 831-835.
18. Treherne, J. M. and Ashford, M. L. J. (1991) The regional distribution of sulfonylurea binding sites in rat brain. Neuroscience 40, 523-532.
19. + in vivo. Eur. J. Pharmacol. 243, 241-247.